Select Page

Dr. Paul Fernyhough

Division of Neurodegenerative Disorders

Principal Investigator,
Cell Biology of Neurodegeneration Lab, Division of Neurodegenerative Disorders

Pharmacology & Therapeutics, University of Manitoba

Division of Neurodegenerative Disorders

The Division of Neurodegenerative Disorders (DND) is housed within the Dr. John Foerster Centre for Health Research on Aging, located in the St-Boniface Hospital Albrechtsen Research Centre. DND was established in 1999 through a major funding initiative “Age of Discovery” by the St-Boniface Hospital Foundation. All faculty in DND hold academic positions in theDepartment of Pharmacology & Therapeutics, University of Manitoba.

St. Boniface Hospital Research celebrates World Alzheimer’s Day

Every year on September 21st, Alzheimer’s organizations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. St. Boniface Hospital Albrechtsen Research Centre is home to world-class Alzheimer’s research!...

Fernyhough group to get SPOR funding

A St. Boniface Hospital Research team has received funding to develop a SPOR (Strategy for Patient-Oriented Research) network. The SPOR Network in Diabetes and Its Related Complications is intended to transform the health outcomes of people with diabetes and its...

Albensi accepted to CCNA

Dr. Benedict Albensi, Principal Investigator, Synaptic Plasticity and Cellular Memory Dysfunction Lab, Division of Neurodegenerative Disorders, has been accepted to the Canadian Consortium on Neurodegeneration in Aging (CCNA). The CCNA provides the infrastructure and...

Dr. Miyoung Suh: KOFST Scientist of the Year

Dr. Miyoung Suh, Principal Investigator, Nutrition and Neurological Diseases, Division of Neurodegenerative Disorders and the Canadian Centre for Agri-Food Research in Health and Medicine, has been named Scientist of the Year by the Korean Federation of Science and...

Albensi research featured in summer issue of Wave

The Summer 2017 issue of Wave, Winnipeg’s Health and Wellness Magazine, features an extensive article on the research of Dr. Benedict Albensi, Principal Investigator of the Synaptic Plasticity and Cellular Memory Dysfunction Lab in the Division of Neurodegenerative...

Fernyhough appointed head of Pharmacology and Therapeutics, U of M

Dr. Paul Fernyhough has been appointed Department Head of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba for a five-year period, effective May 1, 2017.* Dr. Fernyhough was appointed as Acting Head...